Healthed Webcast COVID Expert Update

COVID Update – A/Prof Nick Wood

**REGISTER HERE**

Hear what’s new in the ever-changing COVID landscape from one of Australia’s leading experts.

Make sure you are up-to-date on the latest information on the COVID pandemic. A/Prof Nick Wood will present the latest developments in terms of the illness and its prevention including information on boosters, and what is new in terms of COVID-19 treatment.

Perinatal Depression & Anxiety – Dr Nicole Highet

Depression and anxiety in the perinatal period is a significant problem for many Australian mothers, but how easy are these symptoms to identify in primary care?

Early identification and intervention from frontline health professionals such as GPs and practice nurses can make a huge difference in the mental health and wellbeing trajectory of mothers with this condition. Dr Nicole Highet will cover the evidence-based resources designed to assist health professionals to better identify and manage people with this common problem.

DOAC Dosing in Special Situations – Renal Impairment, Liver Disease and Obesity – Dr Ronald Castellino

Inappropriate DOAC dosing is a common problem, leading to either increased risk of stroke or of iatrogenic bleeding. It’s important to recognise which patients require reduced dosage, such as those with impaired renal clearance, as well as those who are likely to be undertreated. Dr Ronald Castellino will describe the various scenarios in which over- and under-dosing might occur, and what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

IV Iron Induced Hypophosphatemia and Osteomalacia – Cause for Concern? – Prof Peter Ebeling AO

IV iron infusion has been shown to induce hypophosphataemia in a substantial proportion of patients. In many it is transient, but in a small number it can be profound. The effect seems more pronounced with some preparations and less with others – up to 47% of patients following ferric carboxymaltose (FCM) infusions for iron deficiency. However, it is rarely seen following ferric derisomaltose (FDI). If iron infusion-induced hypophosphataemia is severe and long-lasting, it can lead to osteomalacia and bone pain. Recipients of repeated IV iron infusions seem particularly vulnerable to bone effects. Prof Ebeling AO will describe his clinical experience with this phenomenon and the clinical implications for GP